Table 5.
Case and Control Sample Analysis
| Controls (150)
|
Breast cancer (110)
|
Colorectal cancer (99)
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| M | N-M | M | N-M | |||||||
| 15 | 95 | 50 | 49 | |||||||
| CK20+ patients | yes | no | yes | no | yes | no | yes | no | yes | No |
| 0 | 150 | 8 | 7 | 24 | 71 | 13 | 37 | 9 | 40 | |
| Mean no. of CK20 cell equivalents
|
0
|
5.5
|
0.9
|
29.2
|
4.4
|
|||||
| Median no. of CK20 cell equivalents | 0 | 0.1 | 0 | 0 | 0 | |||||
Distribution of subjects by health status (control, breast cancer, colorectal cancer), presence (M) or absence (N-M) of metastases, and presence/absence of CK20 cell-equivalents (yes/no). Mean and median number of CK20 cell equivalents detected in 3 ml of blood.